SHANIKA EBERHARDT: Open Payments
NPI 1598357188 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 55 payments from 20 companies in 2025. Trend: 2023 $1,203 · 2024 $1,458 · 2025 $1,400
Food & beverage: $1,200Education: $200
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $276 |
| Ipsen Biopharmaceuticals, Inc | 2 | $158 |
| AstraZeneca Pharmaceuticals LP | 6 | $153 |
| SOBI, INC | 4 | $144 |
| Gilead Sciences, Inc. | 4 | $85 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Daiichi Sankyo Inc. | 3 | $62 |
| TerSera Therapeutics LLC | 2 | $57 |
| ABBVIE INC. | 2 | $51 |
| Incyte Corporation | 2 | $48 |
Products named: KISQALI, KEYTRUDA, Trodelvy, Onivyde, Zoladex, LUTATHERA, PLUVICTO, JAKAFI.
Industry payments across IL — which companies pay providers there.
